Abbott Laboratories Gross Margin 2006-2019 | ABT

Current and historical gross margin for Abbott Laboratories (ABT) over the last 10 years. The current gross profit margin for Abbott Laboratories as of March 31, 2019 is %.
Abbott Laboratories Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2019-03-31 $30.72B $17.92B 58.34%
2018-12-31 $30.58B $17.87B 58.45%
2018-09-30 $30.40B $17.61B 57.91%
2018-06-30 $29.58B $17.07B 57.71%
2018-03-31 $28.45B $16.03B 56.36%
2017-12-31 $27.39B $14.98B 54.70%
2017-09-30 $25.13B $13.63B 54.21%
2017-06-30 $23.61B $12.69B 53.75%
2017-03-31 $22.30B $12.29B 55.09%
2016-12-31 $20.85B $11.76B 56.39%
2016-09-30 $20.71B $11.79B 56.93%
2016-06-30 $20.56B $11.68B 56.83%
2016-03-31 $20.39B $11.59B 56.82%
2015-12-31 $20.41B $11.66B 57.13%
2015-09-30 $20.57B $11.70B 56.85%
2015-06-30 $20.50B $11.55B 56.32%
2015-03-31 $20.39B $11.36B 55.74%
2014-12-31 $20.25B $11.03B 54.47%
2014-09-30 $18.90B $10.06B 53.21%
2014-06-30 $18.65B $9.87B 52.92%
2014-03-31 $19.03B $10.00B 52.53%
2013-12-31 $19.66B $10.46B 53.23%
2013-09-30 $18.84B $9.92B 52.68%
2013-06-30 $19.28B $10.13B 52.55%
2013-03-31 $19.14B $10.17B 53.13%
2012-12-31 $19.05B $10.15B 53.29%
2012-09-30 $26.24B $15.18B 57.86%
2012-06-30 $30.79B $18.25B 59.27%
2012-03-31 $35.09B $21.05B 59.99%
2011-12-31 $38.85B $23.31B 60.00%
2011-09-30 $38.44B $22.69B 59.03%
2011-06-30 $37.30B $21.78B 58.40%
2011-03-31 $36.51B $21.32B 58.39%
2010-12-31 $35.17B $20.50B 58.30%
2010-09-30 $33.99B $19.58B 57.62%
2010-06-30 $33.08B $19.05B 57.60%
2010-03-31 $31.74B $18.14B 57.13%
2009-12-31 $30.76B $17.56B 57.06%
2009-09-30 $29.92B $17.32B 57.88%
2009-06-30 $29.66B $17.07B 57.53%
2009-03-31 $29.48B $16.89B 57.30%
2008-12-31 $29.53B $16.92B 57.29%
2008-09-30 $28.80B $16.20B 56.27%
2008-06-30 $27.68B $15.57B 56.26%
2008-03-31 $26.74B $14.94B 55.90%
2007-12-31 $25.92B $14.49B 55.93%
2007-09-30 $25.52B $13.98B 54.78%
2007-06-30 $24.71B $13.65B 55.23%
2007-03-31 $23.84B $13.20B 55.34%
2006-12-31 $22.48B $12.66B 56.34%
2006-09-30 $21.70B $12.36B 56.93%
2006-06-30 $21.51B $11.88B 55.22%
2006-03-31 $21.54B $11.66B 54.14%
2005-12-31 $22.34B $11.70B 52.36%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $133.667B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $114.132B 16.69
Stryker (SYK) United States $69.756B 24.90
Boston Scientific (BSX) United States $49.905B 24.25
Baxter (BAX) United States $39.019B 25.03
Zimmer Biomet Holdings (ZBH) United States $25.114B 16.07
Smith & Nephew SNATS (SNN) United Kingdom $16.786B 0.00
Canopy Growth (CGC) Canada $16.315B 0.00
ResMed (RMD) United States $14.544B 27.58
Aurora Cannabis (ACB) Canada $9.179B 64.71
Bio-Rad Laboratories (BIO) United States $8.795B 50.45
Perrigo (PRGO) Ireland $6.734B 10.92
Hill-Rom Holdings (HRC) United States $6.397B 19.79
GW Pharmaceuticals (GWPH) United Kingdom $4.994B 0.00
Insulet (PODD) United States $4.964B 1664.20
ICU Medical (ICUI) United States $4.636B 28.71
Haemonetics (HAE) United States $4.354B 38.62
Hutchison China MediTech (HCM) China $3.962B 0.00
Agios Pharmaceuticals (AGIO) United States $3.443B 0.00
Neogen (NEOG) United States $3.004B 48.85
NuVasive (NUVA) United States $2.967B 25.77
Quidel (QDEL) United States $2.487B 22.25
National Vision Holdings (EYE) United States $2.276B 44.77
Aphria (APHA) $1.957B 0.00
HEXO (HEXO) $1.474B 0.00
Phibro Animal Health (PAHC) United States $1.338B 19.24
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.212B 870.25
AtriCure (ATRC) United States $1.076B 0.00
Lantheus Holdings (LNTH) United States $0.957B 25.86
Omeros (OMER) United States $0.929B 0.00
PetIQ (PETQ) United States $0.865B 24.76
Cerus (CERS) United States $0.831B 0.00
MacroGenics (MGNX) United States $0.820B 0.00
NanoString Technologies (NSTG) United States $0.781B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.725B 24.66
TG Therapeutics (TGTX) United States $0.717B 0.00
Evolus (EOLS) United States $0.708B 0.00
OraSure Technologies (OSUR) United States $0.589B 25.68
Surmodics (SRDX) United States $0.584B 84.94
LeMaitre Vascular (LMAT) United States $0.555B 26.37
Meridian Bioscience (VIVO) United States $0.538B 16.02
Quanterix (QTRX) United States $0.515B 0.00
Insys Therapeutics (INSY) United States $0.332B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.19
BioLife Solutions (BLFS) United States $0.302B 124.61
Vapotherm (VAPO) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.270B 0.00
Cytosorbents (CTSO) United States $0.228B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.172B 18.38
Bovie Medical (APYX) United States $0.140B 0.00
Chimerix (CMRX) United States $0.138B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Surface Oncology (SURF) United States $0.114B 0.00
United-Guardian (UG) United States $0.089B 20.32
Female Health (VERU) United States $0.088B 0.00
InfuSystems Holdings (INFU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
GUARDION HEALTH (GHSI) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.024B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00